Skip to Content
Merck
  • Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.

Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.

International journal of pharmaceutics (2006-01-25)
Mónica Millán, Isidoro Caraballo
ABSTRACT

The main objective of this work is to study the influence of the drug particle size on the pharmaceutical availability of ultrasound compacted tablets. Inert matrix systems containing different drug particle sizes were prepared using both, an ultrasound-assisted press and a traditional eccentric machine. Potassium chloride was used as drug model and Eudragit RS-PM as matrix forming excipient. The excipient particle size was kept constant. The cross-sectional microphotographs of ultrasound tablets show the existence of a quasi-continuum medium. Keeping constant the drug load, US-tablets showed very similar release rates, whereas for traditional tablets, an increase in the particle size resulted in a clear decrease in the release rate. In these tablets, the excipient forms an almost continuum medium. In an infinite theoretical system of these characteristics, the size of the drug particles will not modify the percolation threshold. The percolation of the excipient in this system can be assimilated to a continuum percolation model. In accordance with the proposed model, a lower influence of the drug particle size on the drug release rate was obtained for the US-tablets in comparison with traditional tablets. This fact can be indicative of the similarity of the drug percolation thresholds in these systems.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Potassium chlorate, ACS reagent, ≥99.0%
Sigma-Aldrich
Potassium chlorate, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Millipore
Potassium chlorate Supplement, suitable for microbiology